Product information and disease descriptionPlace of product in therapyApproaches to treatment
Current treatment options and standard of care
42 evidence topics · 15 sources
Duravyu (vorolanib intravitreal insert)
Wet age-related macular degeneration
- Manufacturer
- EyePoint
- Regulatory submission
- NDA planned for the first half of 2027
- Launch
- Not announced
- Last updated